35260-93-6

Basic information

• Product Name: ethyl 2-cyano-3-ethoxybut-2-enoate
• Synonyms: 2-butenoic acid, 2-cyano-3-ethoxy-, ethyl ester; Ethyl 2-cyano-3-ethoxybut-2-enoate; Ethyl ethoxyethylidene cyanoacetate
• CAS NO: 35260-93-6
• Molecular Formula: C₉H₁₃NO₃
• Molecular Weight: 183.2044
• Mol File: 35260-93-6.mol
• Article Data: 21

Chemical Properties

• Boiling Point: 304.6°C at 760 mmHg
• Flash Point: 132°C
• Density: 1.055g/cm³
• Vapor Pressure: 0.000863mmHg at 25°C
• Refractive Index: 1.453
• CAS DataBase Reference: ethyl 2-cyano-3-ethoxybut-2-enoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-cyano-3-ethoxybut-2-enoate(35260-93-6)
• EPA Substance Registry System: ethyl 2-cyano-3-ethoxybut-2-enoate(35260-93-6)

Safety Data

• Hazardous Substances Data: 35260-93-6(Hazardous Substances Data)

Usage

General Description

Ethyl 2-cyano-3-ethoxybut-2-enoate is a chemical compound with a molecular formula C9H13NO3. It is derived from the ester of cyanoacetic acid and ethyl acetoacetate, and is commonly used as a reagent in organic synthesis. The compound is a colorless liquid with a fruity odor, and is flammable. It is utilized in various chemical reactions, including the synthesis of pharmaceuticals and other organic compounds. Ethyl 2-cyano-3-ethoxybut-2-enoate is considered to be a versatile building block in organic chemistry, and its derivatives have a wide range of applications in the pharmaceutical, agrochemical, and fragrance industries.

Upstream product

• 78-39-7 Triethyl orthoacetate 
• 105-56-6 ethyl 2-cyanoacetate 
• 75-03-6 ethyl iodide 
• 186581-53-3 diazomethane 
• 94-05-3 ethyl (ethoxymethylene)cyanoacetate 

Downstream Products

• 25786-72-5 5-amino-3-methyl-4-isoxazolecarboxylic acid ethyl ester 
• 39603-86-6 -cyan-essigsaeureaethylester 
• 86474-54-6 Ethyl 2-cyano-3-N-o-nitroanilinocrotonate 
• 86474-51-3 Ethyl 3-N-m-chloroanilino-2-cyanocrotonate 
• 86474-50-2 Ethyl 3-N-o-chloroanilino-2-cyanocrotonate 
• 86474-55-7 Ethyl 2-cyano-3-N-m-nitroanilinocrotonate 
• 303066-82-2 ethyl 5-amino-1-benzyl-3-methyl-1H-pyrazole-4-carboxylate 
• 115073-23-9 4-Methyl-6-phenyl-1H-pyrazolo[3,4-d]pyrimidin-3-ylamine 
• 914074-37-6 4-chloro-6-methyl-2-phenylpyrimidine-5-carbonitrile 
• 115073-24-0 4-hydrazino-6-methyl-2-phenylpyrimidine-5-carbonitrile 
• 632333-59-6 4,6,8-trimethyl-2-phenylpyrazolo<5,4-d:2,3-a'>dipyrimidine 

Relevant articles and documents

Aromatic ring dioxane quinazoline or quinoline compound, composition and application of aromatic ring dioxane quinazoline or quinoline compound

The invention relates to a novel compound serving as an inhibitor of kinase such as TRK, c-MET, AXL, MER and/or VEGFR2, a composition and application of the novel compound. Specifically, the inventionprovides a compound (as shown in formula (1)) or an isomer, a solvate, a hydrate, a pharmaceutically acceptable salt and a prodrug thereof, and a pharmaceutical composition containing the compound, wherein the compound has the activity of strongly inhibiting kinase such as TRK, c-MET, AXL, MER and/or VEGFR2. The invention further discloses application of the compound or the pharmaceutical composition in preparation of a medicine. The medicine is used for treating autoimmune diseases or cancers.

SUBSTITUTED BICYCLIC HETEROCYCLIC COMPOUNDS AS NADPH OXIDASE INHIBITORS

The present application relates to substituted fused heteroaryl and heterocyclic compounds, useful as nicotinamide adenine dinucleotide phosphate oxidase inhibitors (NADPH oxidase inhibitors), processes for their preparation, pharmaceutical compositions comprising the compounds, and the use of the compounds or the compositions in the treatment or prevention of various diseases, conditions and/or disorders mediated by NADPH oxidase. (Formula I)

COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE

Described herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as Cyp8b1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for diabetes and cardiovascular disease.